SCALE UP AND POSTAPPROVAL CHANGES (SUPAC) GUIDANCE FOR INDUSTRY: A REGULATORY NOTE
Journal Title: International Journal of Drug Regulatory Affairs - Year 2017, Vol 5, Issue 1
Abstract
In today scenario, as per market demand there is definitely carry out an increment or decrease in production, this is called SUPAC. Different guidelines are provided for those different types of SUPAC in by different regulatory authority for manufacturing of product. Here SUPAC guidelines for USFDA are elaborated for production in this review article.
Authors and Affiliations
Mounica N. V. N. , Sharmila Reddy V, Evangeline L, Nagabhushanam M. V. , Nagarjunareddy D, Brahmaiah B.
Keywords
Related Articles
- EP ID EP326650
- DOI 10.22270/ijdra.v5i1.192
- Views 168
- Downloads 0
CURRENT REGULATION OF MEDICAL GASES IN INDIA AND FUTURE ASPECTS
Generally medical gases are administered or supplied directly to the patients. They should be manufactured and transferred with the highest quality possible as per standards and limits decided by the different regulatory...
REGULATORY REQUIREMENTS OF ‘SIMILAR BIOLOGICS’ FOR MARKETING AUTHORIZATION IN INDIA
Present article signifies the exigency for regulation and regulatory bodies involved in development of biosimilars. The principle for development of biosimilars included opting adequate reference product, manufacturing p...
FORMULATION, DEVELOPMENT AND OPTIMIZATION OF MODIFIED RELEASING PELLETS OF DRUG CARVEDILOL
The main objectives of present work was to design and evaluate modified releasing pellets of drug, Carvedilol, in respect to increase patient compliance and therapeutically benefits. The modified releasing pellets were m...
A Comprehensive and Comparative study of qualification process for Drug Development tools in US, Europe, Japan and India
Drug Development Tools are methods, materials, or measures that have the potential to facilitate drug development. USFDA has specified three major drug development tools and has also given the guidelines recommending the...
Scenario of Over the Counter Medicines Worldwide
Over the counter (OTC) drugs are medicines sold directly to consumer without any prescription. The OTC drug market in India is expected to grow by $6.6 billion by 2016 with Pharmaceutical companies and chemists increasin...